Plasma Cell Neoplasms (PCNs) With Low-Risk, Favorable Gene Expression Subtypes Are More Often Associated With Therapy-Related Myelodysplastic Syndrome (t-MDS)

被引：0
|
作者：
Rjoop, Anwar [1 ]
Lobo, Rodolfo Henrich [1 ]
Pandey, Sounlya [1 ]
Alapat, Daisy [1 ]
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2018年 / 150卷
关键词：
D O I：
10.1093/ajcp/aqy097.272
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 22 条
  • [21] Risk score model to predict outcome after allogeneic stem cell transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukaemia. A report from the MDS subcommittee of the Chronic Leukemia Working Party of the EBMT
    Kroeger, N.
    Brand, R.
    van Biezen, A.
    Zander, A.
    Dierlamm, J.
    Niederwieser, D.
    Devergie, A.
    Ruutu, T.
    Cornish, J.
    van der Borne, P.
    Ljungman, P.
    Gratwohl, A.
    Cordonnier, C.
    Beelen, D.
    Deconinck, E.
    Symeonidis, A.
    De Witte, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S211 - S211
  • [22] Remission Status and Performance Status, but Not Cytogenetic Risk Group, Are Associated with Outcome After Reduced Intensity Conditioning (RIC) and Allogeneic Hematopoietic Cell Transplantation (HCT) for Therapy-Related Myeloid Neoplasms (t-MN): Results of the University of Chicago Experience
    Kenkre, Vaishalee P.
    Horowitz, Sarah
    Larson, Richard A.
    Artz, Andrew
    Rich, Elizabeth Shima
    Zhang, Yanming
    Le Beau, Michelle M.
    Godley, Lucy A.
    Odenike, Olatoyosi
    Thirman, Michael
    van Besien, Koen
    Stock, Wendy
    BLOOD, 2009, 114 (22) : 1318 - 1318
123